Exhibit 5.1

August 16, 2017

Board of Directors

Farmland Partners Inc.
4600 S. Syracuse Street, Suite 1450

Denver, Colorado 80237

Re: Public Offering of Series B Participating Preferred Stock

Ladies and Gentlemen:

We are acting as counsel to Farmland Partners Inc., a Maryland corporation (the “Company”), in connection with the public offering of 6,037,500 shares (the “Shares”) (including 787,500 Shares to be issued in connection with the Underwriters’ (as defined below) option to purchase additional Shares) of Series B participating preferred stock, $0.01 par value per share (the “Series B Participating Preferred Stock”), of the Company, all of which Shares are to be sold by the Company pursuant to a prospectus supplement dated August 10, 2017 and the accompanying base prospectus dated May 14, 2015 (such documents, collectively, the “Prospectus”) that form part of the Company’s effective registration statement on Form S-3 (File No. 333-203798) (the “Registration Statement”), filed by the Company with the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”). The Shares are to be sold by the Company pursuant to the terms of the Underwriting Agreement, dated August 10, 2017 (the “Underwriting Agreement”), by and among the Company, Farmland Partners Operating Partnership, LP and Raymond James & Associates, Inc. and Jefferies LLC, as Representative of the several Underwriters named on Schedule A thereto (the “Underwriters”), and in the manner described in the Prospectus.

As counsel for the Company, we have examined the Underwriting Agreement, the Registration Statement, the Prospectus, the Company’s Articles of Amendment and Restatement, as amended and supplemented (including the Articles Supplementary (the “Articles Supplementary”) designating the terms of the Series B Participating Preferred Stock, the “Charter”) and the Company’s Amended and Restated Bylaws, as well as originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary for the purposes of rendering this opinion and we are familiar with the proceedings taken and proposed to be taken by the Company in with the authorization, issuance and sale of the Shares.  In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity with the originals of all documents submitted to us as copies.  We also have assumed that the Shares and the shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), issuable upon

conversion of the Shares (the “Conversion Shares”) will not be issued in violation of the ownership limit contained in the Company’s Charter. We have further assumed that, upon the issuance of any of the Shares or the Conversion Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Charter.  This opinion letter is given, and all statements herein are made, in the context of the foregoing.

This opinion letter is based as to matters of law solely on the Maryland General Corporation Law, as amended. We express no opinion herein as to any other laws, statutes, ordinances, rules, or regulations. As used herein, the term “Maryland General Corporation Law, as amended” includes the statutory provisions contained therein, all applicable provisions of the Maryland Constitution and reported judicial decisions interpreting these laws.

Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that following (i) the filing of the Articles Supplementary, (ii) issuance and delivery of the Shares pursuant to the terms of the Underwriting Agreement, (iii) receipt by the Company of the consideration for the Shares specified in the resolutions of the Board of Directors and the Pricing Committee of the Board of Directors and in the Underwriting Agreement, and (iv) in the case of the Conversion Shares, a determination by the Board of Directors to convert the Shares and issue the Conversion Shares in accordance with the terms of the Articles Supplementary, the Shares and the Conversion Shares will, when issued in accordance with the Articles Supplementary, be validly issued, fully paid, and non-assessable.

This opinion is furnished to you in connection with the filing by the Company of a Current Report on Form 8-K relating to the offer and sale of the Shares, which Form 8-K will be incorporated by reference into the Registration Statement and Prospectus, and may not be relied upon for any other purpose without our express written consent. No opinion may be implied or inferred beyond the opinion expressly stated. This opinion is given as of the date hereof, and we assume no obligation to advise you of any changes in applicable law or any facts or circumstances that come to our attention after the date hereof that may affect the opinion contained herein.

We hereby consent to the filing of this opinion as an exhibit to the above-described Current Report on Form 8-K and to the reference to our firm contained under the heading “Legal Matters” in the Prospectus. In giving this consent, we do not admit that we are in the category of persons whose consent is required by Section 7 of the Securities Act or the rules and regulations promulgated by the Commission.